
New diagnostic standards for Alzheimer's disease were unveiled at the International Alzheimer's Congress in Amsterdam. The new approach uses blood biomarkers, making diagnosis less invasive and more accessible than previous methods. This method offers effective Alzheimer's detection and is gaining momentum with the development of more biomarkers. Targeted therapies like lecanemab are also promising.
Like
Save
Share